0 valutazioniIl 0% ha trovato utile questo documento (0 voti)
1K visualizzazioni1 pagina
This document provides information about the medication ondansetron (Zofran) including its classification, dose, route, and timing. It lists compatibility and stability information for intravenous administration. The mechanisms of action, indications, nursing implications, and the nursing process for assessment and evaluation are also summarized. Key points include that ondansetron is an antiemetic used to prevent nausea and vomiting from chemotherapy, it has a rapid onset and 4-8 hour duration, and nurses should monitor for potential side effects or interactions.
This document provides information about the medication ondansetron (Zofran) including its classification, dose, route, and timing. It lists compatibility and stability information for intravenous administration. The mechanisms of action, indications, nursing implications, and the nursing process for assessment and evaluation are also summarized. Key points include that ondansetron is an antiemetic used to prevent nausea and vomiting from chemotherapy, it has a rapid onset and 4-8 hour duration, and nurses should monitor for potential side effects or interactions.
Copyright:
Attribution Non-Commercial (BY-NC)
Formati disponibili
Scarica in formato DOC, PDF, TXT o leggi online su Scribd
This document provides information about the medication ondansetron (Zofran) including its classification, dose, route, and timing. It lists compatibility and stability information for intravenous administration. The mechanisms of action, indications, nursing implications, and the nursing process for assessment and evaluation are also summarized. Key points include that ondansetron is an antiemetic used to prevent nausea and vomiting from chemotherapy, it has a rapid onset and 4-8 hour duration, and nurses should monitor for potential side effects or interactions.
Copyright:
Attribution Non-Commercial (BY-NC)
Formati disponibili
Scarica in formato DOC, PDF, TXT o leggi online su Scribd
(You will need to make additional copies of these forms)
Generic Name Trade Name Classification Dose Route Time/frequency
ondansetron Zofran antiemetics 3 mg IVP Q 6 hr. PRN Peak Onset Duration For IV meds, compatibility with IV drips and /or solutions 15-30 min rapid 4 hr-8 hr Dilute doses for prevention of nausea and vomiting associated with chemotherapy in 50 ml of D5W, 0.9% NaCl, D5/0.9% NaCl, D5/0.45% NaCl. Solution is clear and colorless. Stable for 7 days at room temperature following dilution. Y-Site Incompatibility: ♦acyclovir ♦allopurinol ♦aminophylline ♦amphotericin B ♦ amphotericin B cholesteryl sulfate ♦ampicillin ♦ampicillin/sulbactam ♦cefepime ♦cefoperazone ♦furosemide ♦ganciclovir ♦lorazepam ♦methylprednisolone sodium succinate ♦piperacillin ♦sargramostim ♦sodium bicarbonate Mechanism of action and indications Nursing Implications (what to focus on) (Why med ordered) Contraindications/warnings/interactions Prevention of nausea and vomiting Hypersensitivity Blocks the effects of serotonin at 5-HT3-receptor sites (selective antagonist) located in vagal nerve terminals and the Common side effects chemoreceptor trigger zone in the CNS CNS: headache, dizziness, drowsiness, fatigue, weakness, GI: constipation, diarrhea, abdominal pain, dry mouth, increased liver enzymes, Neuro: extrapyramidal reactions Interactions with other patient drugs, OTC or herbal Lab value alterations caused by medicine medicines (ask patient specifically) May cause transient ↑ in serum bilirubin, AST, and ALT levels May be affected by drugs altering the activity of liver enzymes Be sure to teach the patient the following about this medication Advise patient to notify health care professional immediately if involuntary movement of eyes, face, or limbs occurs Nursing Process- Assessment Assessment Evaluation (Pre-administration assessment) Why would you hold or not give this Check after giving Assess patient for nausea, vomiting, abdominal med? Assess patient for extrapyramidal Prevention of nausea and distention, and bowel sounds prior to and effects (involuntary movements, facial vomiting following administration grimacing, rigidity, shuffling walk, trembling of hands)